CO6821951A2 - Combinación que comprende umeclidinio y un corticosteroide - Google Patents
Combinación que comprende umeclidinio y un corticosteroideInfo
- Publication number
- CO6821951A2 CO6821951A2 CO13287946A CO13287946A CO6821951A2 CO 6821951 A2 CO6821951 A2 CO 6821951A2 CO 13287946 A CO13287946 A CO 13287946A CO 13287946 A CO13287946 A CO 13287946A CO 6821951 A2 CO6821951 A2 CO 6821951A2
- Authority
- CO
- Colombia
- Prior art keywords
- umeclidinium
- corticosteroid
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161494600P | 2011-06-08 | 2011-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6821951A2 true CO6821951A2 (es) | 2013-12-31 |
Family
ID=46201674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13287946A CO6821951A2 (es) | 2011-06-08 | 2013-12-09 | Combinación que comprende umeclidinio y un corticosteroide |
Country Status (20)
Country | Link |
---|---|
US (1) | US20140113888A1 (es) |
EP (1) | EP2717868A1 (es) |
JP (1) | JP2014516062A (es) |
KR (1) | KR20140041699A (es) |
CN (1) | CN103582477A (es) |
AU (1) | AU2012266541A1 (es) |
BR (1) | BR112013031572A2 (es) |
CA (1) | CA2838030A1 (es) |
CL (1) | CL2013003497A1 (es) |
CO (1) | CO6821951A2 (es) |
CR (1) | CR20130643A (es) |
DO (1) | DOP2013000290A (es) |
EA (1) | EA201391618A1 (es) |
IL (1) | IL229633A0 (es) |
MA (1) | MA35406B1 (es) |
MX (1) | MX2013014399A (es) |
PE (1) | PE20141048A1 (es) |
PH (1) | PH12013502497A1 (es) |
SG (1) | SG195262A1 (es) |
WO (1) | WO2012168161A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010097115A1 (en) | 2009-02-26 | 2010-09-02 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
JP5797778B2 (ja) | 2011-12-28 | 2015-10-21 | 旭化成イーマテリアルズ株式会社 | レドックスフロー二次電池及びレドックスフロー二次電池用電解質膜 |
RU2666963C2 (ru) | 2012-04-13 | 2018-09-13 | Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Агрегированные частицы |
GB201222679D0 (en) | 2012-12-17 | 2013-01-30 | Glaxo Group Ltd | Pharmaceutical combination products |
GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
EP4252742A3 (en) | 2014-05-28 | 2023-12-27 | GlaxoSmithKline Intellectual Property Development Ltd | Fluticasone furoate in the treatment of copd |
WO2015193631A1 (en) | 2014-06-18 | 2015-12-23 | Cipla Limited | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent |
CN107200734B (zh) * | 2016-03-18 | 2019-12-24 | 益方生物科技(上海)有限公司 | 奎宁环衍生物及其制备方法和用途 |
TR201712424A2 (tr) * | 2017-08-21 | 2019-03-21 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Kuru toz i̇nhalasyon bi̇leşi̇mleri̇ |
US20210353650A1 (en) * | 2020-05-18 | 2021-11-18 | Cai Gu Huang | Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
KR100321649B1 (ko) | 1993-03-17 | 2002-07-22 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제 |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
IL154148A0 (en) | 2000-08-05 | 2003-07-31 | Glaxo Group Ltd | 6.alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
SE527191C2 (sv) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhalatoranordning samt kombinerade doser av tiotropium och fluticason |
MY144753A (en) | 2004-04-27 | 2011-10-31 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
PE20060826A1 (es) * | 2004-12-06 | 2006-10-08 | Smithkline Beecham Corp | Derivado oleofinico de 8-azoniabiciclo[3.2.1]octano y combinacion farmaceutica que lo comprende |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
RU2010108640A (ru) * | 2007-09-12 | 2011-10-20 | Глаксо Груп Лимитед (GB) | Новая комбинация терапевтических агентов |
WO2010097115A1 (en) * | 2009-02-26 | 2010-09-02 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1r)-2- [(6-{2-[(2,6-dichlorobenzyl)oxy] ethoxy}hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol |
GB0921075D0 (en) * | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
-
2012
- 2012-06-01 EP EP12725047.0A patent/EP2717868A1/en not_active Withdrawn
- 2012-06-01 CN CN201280027664.6A patent/CN103582477A/zh active Pending
- 2012-06-01 WO PCT/EP2012/060444 patent/WO2012168161A1/en active Application Filing
- 2012-06-01 MX MX2013014399A patent/MX2013014399A/es unknown
- 2012-06-01 AU AU2012266541A patent/AU2012266541A1/en not_active Abandoned
- 2012-06-01 EA EA201391618A patent/EA201391618A1/ru unknown
- 2012-06-01 CA CA2838030A patent/CA2838030A1/en not_active Abandoned
- 2012-06-01 BR BR112013031572A patent/BR112013031572A2/pt not_active IP Right Cessation
- 2012-06-01 SG SG2013089123A patent/SG195262A1/en unknown
- 2012-06-01 PH PH1/2013/502497A patent/PH12013502497A1/en unknown
- 2012-06-01 PE PE2013002753A patent/PE20141048A1/es not_active Application Discontinuation
- 2012-06-01 US US14/124,276 patent/US20140113888A1/en not_active Abandoned
- 2012-06-01 KR KR1020147000491A patent/KR20140041699A/ko not_active Application Discontinuation
- 2012-06-01 JP JP2014514008A patent/JP2014516062A/ja active Pending
-
2013
- 2013-11-26 IL IL229633A patent/IL229633A0/en unknown
- 2013-12-05 CL CL2013003497A patent/CL2013003497A1/es unknown
- 2013-12-06 DO DO2013000290A patent/DOP2013000290A/es unknown
- 2013-12-09 CO CO13287946A patent/CO6821951A2/es not_active Application Discontinuation
- 2013-12-09 CR CR20130643A patent/CR20130643A/es unknown
-
2014
- 2014-01-03 MA MA36643A patent/MA35406B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EA201391618A1 (ru) | 2014-05-30 |
NZ618166A (en) | 2016-01-29 |
WO2012168161A1 (en) | 2012-12-13 |
MX2013014399A (es) | 2014-03-21 |
EP2717868A1 (en) | 2014-04-16 |
KR20140041699A (ko) | 2014-04-04 |
DOP2013000290A (es) | 2014-03-16 |
BR112013031572A2 (pt) | 2017-03-21 |
JP2014516062A (ja) | 2014-07-07 |
SG195262A1 (en) | 2013-12-30 |
US20140113888A1 (en) | 2014-04-24 |
CA2838030A1 (en) | 2012-12-13 |
IL229633A0 (en) | 2014-01-30 |
CL2013003497A1 (es) | 2014-07-04 |
PE20141048A1 (es) | 2014-09-08 |
CN103582477A (zh) | 2014-02-12 |
AU2012266541A1 (en) | 2014-01-09 |
PH12013502497A1 (en) | 2019-07-17 |
CR20130643A (es) | 2014-02-04 |
MA35406B1 (fr) | 2014-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6821951A2 (es) | Combinación que comprende umeclidinio y un corticosteroide | |
NO2018034I1 (no) | Testosteron | |
DE112012000884A5 (de) | Durchführung | |
IL229621A0 (en) | Multi-application environment | |
BR112013032502A2 (pt) | propagandas em vizualização | |
CO6990720A2 (es) | Composiciones que comprenden galatos y galamidas | |
EP2820198A4 (en) | MODULAR WALL INTERNAL FUNCTIONAL LINES | |
ITMI20121896A1 (it) | Mems-chippackage e procedimento per fabbricare un mems-chippackage | |
EP2788947A4 (en) | EDITING DESIGNER | |
EP2754052A4 (en) | ORGANIZATION AND REPRESENTATION OF PARTITION IN POOL | |
BR112013033944A2 (pt) | combinação sinérgica | |
EP2718374A4 (en) | CORE CASE MICRO BALLS | |
ES2579654T8 (es) | Aparato mezclador y dispensador | |
FI20116089L (fi) | Järjestely ja laite | |
CO6811882A2 (es) | Un agente sustentante | |
BR112014010157A2 (pt) | adaptação da linguagem usada em um dispositivo | |
EP2783258A4 (en) | TONER AND DEVELOPER | |
BR112014023854A2 (pt) | Método para montar um distalizador e distalizador | |
CO6990713A2 (es) | Preparaciones que comprenden emodépsido amorfo | |
BRDI7106112S (pt) | Configuração aplicada a grill | |
FI20115409A (fi) | Kiinnityselementti | |
CO6930331A2 (es) | Difusor | |
BR112013015487A2 (pt) | composições e métodos relacionados a carotenóides. | |
FR2991273B1 (fr) | Servofrein a depression | |
CO6940403A2 (es) | Un artículo absorbente que tiene una porción discreta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |